Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10112608 | 0.95 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL30998078 | 0.91 | L3MBTL1 (0.41) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL490488 | 0.91 | L3MBTL1 (0.41) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL10112459 | 0.89 | L3MBTL1 (0.39) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL8406170 | 0.89 | L3MBTL1 (0.39) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL8406164 | 0.89 | L3MBTL1 (0.39) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL10112440 | 0.86 | KDM4E (0.37) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL10112604 | 0.86 | KDM4E (0.37) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL10112363 | 0.85 | — | — | |
| SCHEMBL10112488 | 0.84 | FOLH1 (0.40) | KDM4EATML3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110980-B2 | Anthracene derivative, and light emitting element, light emitting device, electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20100164376-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-07-01 | — | — | US | disclosed |
| US-7674914-B2 | novel anthracene derivative represented by General Formula (1) is provided, which enables the production of a light-emitting element with high luminous efficiency and a long lifetime. A high-performance light-emitting device and electronic device in which the anthracene derivative light emitting diode | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-03-09 | — | — | US | disclosed |
| US-20080103315-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103315-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | AMY1A, CYP1A1, CRY1 | KDM4E 3476/4885ATM 942/4885L3MBTL1 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.